1. news events
  2. Newsroom
  3. Nanomaterials Designed to Reduce Off-Target Effects of Cancer Drugs

Nanomaterials Designed to Reduce Off-Target Effects of Cancer Drugs

NIBIB in the News
May 20, 2022

This NIBIB-funded research is focused on creating a new group of nanomaterials designed to capture chemotherapy drugs before they impact healthy tissue. Source: AzoNano

Explore More

There is so much more to explore at NIBIB.

Health Topics

Cancer

Research Topics

Biomaterials

Program Areas

Biomaterial Interfaces

Divisions

Division of Discovery Science & Technology (Bioengineering)